Inovio Pharmaceuticals (INO) Earnings Date & Reports

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

INO is expected to report earnings to rise 200.00% to -20 cents per share on November 10

Inovio Pharmaceuticals INO Stock Earnings Reports

Q3'26

Est.

$-0.21

Q2'26

Beat

by $0.18

Q1'26

Beat

by $0.16

Q4'25

Missed

by $1.14

Q3'25

Beat

by $0.12

The last earnings report on August 12 showed earnings per share of -7 cents, beating the estimate of -25 cents. With 2.04M shares outstanding, the current market capitalization sits at 133.38M.

View a ticker or compare two or three

INO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for INO